Global Blood Preparation Market Research Report

 The findings reviewed by GME stated that the Global Blood Preparation Market will expand with a CAGR value of 4.8 percent from 2021 to 2026. The growing demand for blood transfusions and blood components during and after surgeries are expected to be the major drivers of the blood preparation market.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Blood Preparation Market - Forecast to 2026" 

https://www.globalmarketestimates.com/market-report/global-blood-preparation-market-3087

By Product (Whole Blood, Derivatives, and Components), By Antithrombotic and Anticoagulants Type (Platelet Aggregation Inhibitors, Fibrinolytic, And Anticoagulants), By Antithrombotic and AnticoagulantsApplication (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, And Others), By Region (North America, Asia Pacific, CSA, Europe, And The Middle East And Africa); End-User Landscape, Company Market Share Analysis &Competitor Analysis

 Key Market Insights

·         Blood preparation is vital in many treatment procedures especially for life-threatening disorders that require major surgery.

·         The increasing investments in research & development of novel antithrombotic and anticoagulants are expected to increase the demand for blood preparation.

·         The thrombocytosis segment is analyzed to be the top segment as per revenue share from 2021-2026

·         Sanofi S.A., Baxter International Inc., GlaxoSmithKline PLC, LEO Pharma A/S, AstraZeneca PLC, Pfizer Inc., Bristol-Myers Squibb Company, and Portola Pharmaceuticals Inc., among others, are the major vendors competing in the blood preparation market.

 

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-blood-preparation-market-3087

Product Outlook (Revenue, USD Billion, 2021-2026)

·         Whole Blood

·         Separation Tools

·         Red Cells

·         Granulocytes

·         Plasma

·         Platelets

·         Blood Components

·         Whole Blood Components

·         Packed Red Cells

·         Leukocyte Reduced Red Blood Cells

·         Frozen Plasma

·         Platelet Concentrate

·         Cryoprecipitate

·         Blood Derivatives

Antithrombotic and Anticoagulants Type Outlook (Revenue, USD Billion, 2021-2026)

·         Platelet Aggregation Inhibitors

·         Glycoprotein Inhibitors

·         COX Inhibitors

·         ADP Antagonists

·         Others

·         Fibrinolytics

·         Tissue Plasminogen Activator (tPA)

·         Streptokinase

·         Urokinase

·         Anticoagulants

·         Heparins

§  Unfractionated Heparin

§  Low Molecular Weight Heparin (LMWH)

§  Ultra-low Molecular Weight Heparin

·         Vitamin K Antagonists

·         Direct Thrombin Inhibitors

·         Direct Factor Xa Inhibitors

 

Antithrombotic and Anticoagulants Application Outlook (Revenue, USD Billion, 2021-2026)

·         Thrombocytosis

·         Pulmonary Embolism

·         Renal Impairment

·         Angina Blood Vessel Complications

·         Others

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

 

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php